Home  >  Products  >  Bnip3l (BCL2/adenovirus E1B interacting protein 3-like ) Blocking Peptide (the middle region of Bnip3l)(100ug)
Bnip3l (BCL2/adenovirus E1B interacting protein 3-like ) Blocking Peptide (the middle region of Bnip3l)(100ug)

Bnip3l (BCL2/adenovirus E1B interacting protein 3-like ) Blocking Peptide (the middle region of Bnip3l)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Bnip3l Antibody (ARP58878_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Mouse
Presku: AAP58878
Size: 100ug
Weight: 24kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Bnip3l induces apoptosis. It interacts with viral and cellular anti-apoptosis proteins. It can overcome the suppressors BCL-2 and BCL-XL, although high levels of BCL-XL expression will inhibit apoptosis. It inhibits apoptosis induced by BNIP3. It is involved in mitochondrial quality control via its interaction with SPATA18/MIEAP: in response to mitochondrial damage, participates to mitochondrial protein catabolic process (also named MALM) leading to the degradation of damaged proteins inside mitochondria. Bnip3l may function as a tumor suppressor.
Alternative names: C86132; D14Ertd719e; Nip3L; Nix
See Full Product Listings >